You are here

  • Home
  • Archive
  • Volume 81, Issue 6
  • Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial

Citation Tools

Article menu
Epidemiology
Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Araujo CSR, Medeiros-Ribeiro AC, Saad CGS, et al
Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial
Annals of the Rheumatic Diseases 2022;81:889-897.